CLEAR: lenvatinib and pembrolizumab in advanced renal cell carcinoma VJOncology 0:49 1 year ago 967 Скачать Далее
Assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma VJOncology 1:44 5 months ago 144 Скачать Далее
Lenvatinib and Pembrolizumab Compared to Sunitinib for Advanced Renal Cell Carcinoma PracticeUpdate 10:06 3 years ago 812 Скачать Далее
Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationale VJOncology 0:59 11 months ago 184 Скачать Далее
Lenvatinib plus pembro for aRCC - update on the CLEAR study ecancer 2:06 1 year ago 360 Скачать Далее
Len + pembro metastatic clear cell renal cell carcinoma VJOncology 2:32 4 years ago 553 Скачать Далее
CLEAR: lenvatinib and pembrolizumab efficacy in aRCC across baseline tumor sizes VJOncology 2:08 5 months ago 171 Скачать Далее
KEYNOTE-B61: first-line lenvatinib + pembrolizumab in non-clear cell RCC VJOncology 1:28 11 months ago 112 Скачать Далее
Lenvatinib Pembrolizumab in RCC, the CLEAR trial with Karine Tawagi Vinay Prasad MD MPH 32:46 3 years ago 1 738 Скачать Далее
Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC PeerView Oncology 38:09 4 years ago 135 Скачать Далее
Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023 Touch Medical Media Services 51:09 1 year ago 2 502 Скачать Далее
Subgroup analyses in the CLEAR study of lenvatinib plus pembrolizumab versus sunitinib in RCC VJOncology 1:58 3 years ago 435 Скачать Далее
VEGFR inhibitors with immune checkpoint inhibitors for advanced renal cancer VJOncology 4:44 3 years ago 341 Скачать Далее
Lesion responses to lenvatinib and pembrolizumab based on organ sites VJOncology 2:03 8 months ago 57 Скачать Далее
